United States Pharmaceuticals

Ocular Therapeutix, Inc. (OCUL)

Ocular Therapeutix experienced significant selling activity recently, with executives offloading over 1.3 million dollars in stock. These transactions occurred amid a 28.6 percent decline in share price over the last quarter. Following their August results financiers, multiple officers executed planned divestments, reflecting a net negative insider sentiment as the company approaches its next reporting cycle.
Ticker: OCUL Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Ocular Therapeutix, Inc.. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.1
Saroj Namrata Chief Business Officer Officer
Transaction date
Planned sale
Price
200.93
Quantity 55,089 -43.3%
Value US$2,757,894
2.1
NAMRATA SAROJ Officer Officer
Transaction date
Proposed sale
Price
312.31
Quantity 13,092
Value US$527,258
3.1
Anderman Todd Chief Legal Officer Officer
Transaction date
Sale
Price
281.20
Quantity 98,841 -15.0%
Value US$1,436,092
3.1
TODD ANDERMAN Officer Officer
Transaction date
Proposed sale
Price
7.29
Quantity 11,984
Value US$87,315
2.7
Kaiser Peter Chief Development Officer Officer
Transaction date
Sale
Price
7.05
Quantity 9,990 -3.8%
Value US$70,430
3.7
Heier Jeffrey S. Chief Scientific Officer Officer
Transaction date
Sale
Price
7.05
Quantity 10,869 -3.4%
Value US$76,626
2.7
PETER KAZUO KAISER Officer Officer
Transaction date
Proposed sale
Price
7.05
Quantity 9,990
Value US$70,459
3.7
JEFFREY S. HEIER Officer Officer
Transaction date
Proposed sale
Price
7.05
Quantity 10,869
Value US$76,639
2.2
Notman Donald Chief Operating Officer Officer
Transaction date
Planned sale
Price
10.24
Quantity 1,099 -0.3%
Value US$11,254
2.2
DONALD D NOTMAN JR. Officer Officer
Transaction date
Proposed sale
Price
10.24
Quantity 1,099
Value US$11,252
2.7
Kaiser Peter Chief Development Officer Officer
Transaction date
Planned sale
Price
10.77
Quantity 3,035 -1.1%
Value US$32,687
2.9
Dugel Pravin See Remarks Executive Director
Transaction date
Sale
Price
10.77
Quantity 21,649 -0.8%
Value US$233,160
2.8
Nayak Sanjay Chief Strategy Officer Officer
Transaction date
Sale
Price
10.78
Quantity 1,897 -0.6%
Value US$20,450
3.7
Heier Jeffrey S. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
10.78
Quantity 3,296 -1.0%
Value US$35,531
2.8
SANJAY NAYAK Officer Officer
Transaction date
Proposed sale
Price
10.78
Quantity 1,897
Value US$20,453
2.9
PRAVIN DUGEL Officer Officer
Transaction date
Proposed sale
Price
10.77
Quantity 21,649
Value US$233,186
3.7
JEFFREY S. HEIER Officer Officer
Transaction date
Proposed sale
Price
10.78
Quantity 3,296
Value US$35,532
2.7
PETER KAZUO KAISER Officer Officer
Transaction date
Proposed sale
Price
10.77
Quantity 3,035
Value US$32,702
1.9
Waheed Nadia Chief Medical Officer Officer
Transaction date
Sale
Price
8.27
Quantity 14,828 -4.7%
Value US$122,628
1.9
Waheed Nadia Chief Medical Officer Officer
Transaction date
Sale
Price
8.27
Quantity 14,828 -4.7%
Value US$122,628
1.9
NADIA K. WAHEED Officer Officer
Transaction date
Proposed sale
Price
8.27
Quantity 14,828
Value US$122,648
2.9
Dugel Pravin See Remarks Executive Director
Transaction date
Sale
Price
8.20
Quantity 21,156 -0.8%
Value US$173,479
3.7
Heier Jeffrey S. Chief Scientific Officer Officer
Transaction date
Sale
Price
8.20
Quantity 3,018 -0.9%
Value US$24,748
2.7
Kaiser Peter Chief Development Officer Officer
Transaction date
Sale
Price
8.20
Quantity 2,967 -1.1%
Value US$24,329
2.8
Nayak Sanjay Chief Strategy Officer Officer
Transaction date
Sale
Price
8.20
Quantity 1,858 -0.6%
Value US$15,236
2.8
SANJAY NAYAK Officer Officer
Transaction date
Proposed sale
Price
8.20
Quantity 1,858
Value US$15,237
2.7
PETER KAZUO KAISER Officer Officer
Transaction date
Proposed sale
Price
8.20
Quantity 2,967
Value US$24,334
3.7
JEFFREY S. HEIER Officer Officer
Transaction date
Proposed sale
Price
8.20
Quantity 3,018
Value US$24,745
2.9
PRAVIN DUGEL Officer Officer
Transaction date
Proposed sale
Price
8.20
Quantity 21,156
Value US$173,513
2.9
Dugel Pravin See Remarks Executive Director
Transaction date
Sale
Price
8.28
Quantity 20,056 -0.7%
Value US$166,064
2.7
Kaiser Peter Chief Development Officer Officer
Transaction date
Sale
Price
8.28
Quantity 2,810 -1.0%
Value US$23,267
3.7
Heier Jeffrey S. Chief Scientific Officer Officer
Transaction date
Sale
Price
8.28
Quantity 3,057 -0.9%
Value US$25,312
2.8
Nayak Sanjay Chief Strategy Officer Officer
Transaction date
Sale
Price
8.28
Quantity 1,759 -0.5%
Value US$14,565
2.7
PETER KAZUO KAISER Officer Officer
Transaction date
Proposed sale
Price
8.28
Quantity 2,810
Value US$23,268
2.9
PRAVIN DUGEL Officer Officer
Transaction date
Proposed sale
Price
8.28
Quantity 20,056
Value US$166,086
3.7
JEFFREY S. HEIER Officer Officer
Transaction date
Proposed sale
Price
8.28
Quantity 3,057
Value US$25,298
2.8
SANJAY NAYAK Officer Officer
Transaction date
Proposed sale
Price
8.28
Quantity 1,759
Value US$14,563
1.9
Waheed Nadia Chief Medical Officer Officer
Transaction date
Sale
Price
7.74
Quantity 3,510 -1.1%
Value US$27,167
3.4
LINDSTROM RICHARD L MD Non-Executive Director
Transaction date
Purchase
Price
7.66
Quantity 60,229 +32.3%
Value US$461,354
1.9
NADIA K. WAHEED Officer Officer
Transaction date
Proposed sale
Price
7.74
Quantity 3,510
Value US$27,170
2.2
Notman Donald Chief Operating Officer Officer
Transaction date
Sale
Price
9.04
Quantity 11,446 -3.0%
Value US$103,472
2.8
Nayak Sanjay Chief Strategy Officer Officer
Transaction date
Sale
Price
9.04
Quantity 10,348 -3.0%
Value US$93,546
2.9
Dugel Pravin See Remarks Executive Director
Transaction date
Sale
Price
9.04
Quantity 124,882 -4.0%
Value US$1,128,933
1.9
Waheed Nadia Chief Medical Officer Officer
Transaction date
Sale
Price
9.04
Quantity 7,863 -2.4%
Value US$71,082
2.2
DONALD D NOTMAN JR. Officer Officer
Transaction date
Proposed sale
Price
9.04
Quantity 11,446
Value US$103,481
2.9
PRAVIN DUGEL Officer Officer
Transaction date
Proposed sale
Price
9.04
Quantity 124,882
Value US$1,128,584
STEVE MEYERS Officer Officer
Transaction date
Proposed sale
Price
9.04
Quantity 6,864
Value US$62,034
2.8
SANJAY NAYAK Officer Officer
Transaction date
Proposed sale
Price
9.04
Quantity 10,348
Value US$93,560
1.9
NADIA K. WAHEED Officer Officer
Transaction date
Proposed sale
Price
9.04
Quantity 7,863
Value US$71,082
2.2
Notman Donald Chief Operating Officer Officer
Transaction date
Sale
Price
8.54
Quantity 6,035 -1.6%
Value US$51,539
2.2
Notman Donald Chief Operating Officer Officer
Transaction date
Sale
Price
8.54
Quantity 6,035 -1.6%
Value US$51,539
STEVE MEYERS Officer Officer
Transaction date
Proposed sale
Price
8.54
Quantity 4,408
Value US$37,636
2.2
DONALD D NOTMAN JR. Officer Officer
Transaction date
Proposed sale
Price
8.54
Quantity 6,035
Value US$51,541
2.2
Notman Donald Chief Operating Officer Officer
Transaction date
Sale
Price
9.14
Quantity 5,455 -1.4%
Value US$49,859
2.2
DONALD D NOTMAN JR. Officer Officer
Transaction date
Proposed sale
Price
9.14
Quantity 5,455
Value US$49,873
STEVE MEYERS Officer Officer
Transaction date
Proposed sale
Price
9.14
Quantity 3,052
Value US$27,904
2.7
Kaiser Peter Chief Development Officer Officer
Transaction date
Sale
Price
12.02
Quantity 3,007 -1.5%
Value US$36,144
3.7
Heier Jeffrey S. Chief Scientific Officer Officer
Transaction date
Sale
Price
12.04
Quantity 3,469 -1.4%
Value US$41,767
2.8
Nayak Sanjay Chief Strategy Officer Officer
Transaction date
Sale
Price
12.04
Quantity 1,878 -0.7%
Value US$22,611
2.9
Dugel Pravin See Remarks Executive Director
Transaction date
Sale
Price
12.04
Quantity 19,530 -0.6%
Value US$235,141
2.9
PRAVIN DUGEL Officer Officer
Transaction date
Proposed sale
Price
12.04
Quantity 19,530
Value US$235,083
2.8
SANJAY NAYAK Officer Officer
Transaction date
Proposed sale
Price
12.04
Quantity 1,878
Value US$22,616
2.7
PETER KAZUO KAISER Officer Officer
Transaction date
Proposed sale
Price
12.02
Quantity 3,007
Value US$36,150
3.7
JEFFREY S. HEIER Officer Officer
Transaction date
Proposed sale
Price
12.04
Quantity 3,469
Value US$41,772
2.1
Saroj Namrata Chief Business Officer Officer
Transaction date
Sale
Price
10.74
Quantity 25,865 -12.9%
Value US$277,790
2.1
NAMRATA SAROJ Officer Officer
Transaction date
Proposed sale
Price
10.74
Quantity 25,865
Value US$277,909
3.1
Anderman Todd Chief Legal Officer Officer
Transaction date
Sale
Price
12.34
Quantity 11,132 -11.3%
Value US$137,369
3.1
TODD ANDERMAN Officer Officer
Transaction date
Proposed sale
Price
12.34
Quantity 11,132
Value US$137,400
3.7
Heier Jeffrey S. Chief Scientific Officer Officer
Transaction date
Sale
Price
11.04
Quantity 10,502 -4.0%
Value US$115,942
2.7
Kaiser Peter Chief Development Officer Officer
Transaction date
Sale
Price
11.03
Quantity 9,653 -4.7%
Value US$106,473
3.7
JEFFREY S. HEIER Officer Officer
Transaction date
Proposed sale
Price
11.04
Quantity 10,502
Value US$115,890
2.7
PETER KAZUO KAISER Officer Officer
Transaction date
Proposed sale
Price
11.03
Quantity 9,653
Value US$106,516
2.2
Notman Donald See Remarks Officer
Transaction date
Planned sale
Price
12.43
Quantity 1,066 -0.3%
Value US$13,250
2.2
DONALD D NOTMAN JR. Officer Officer
Transaction date
Proposed sale
Price
12.43
Quantity 1,066
Value US$13,245
3.7
Heier Jeffrey S. Chief Scientific Officer Officer
Transaction date
Sale
Price
12.04
Quantity 3,063 -1.2%
Value US$36,879
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-11-09 2026-11-05 PlS Planned sale
2.1
Saroj Namrata

Chief Business Officer

Officer
55,089 -43.3%
200.93
US$2,757,894 		55,089 -43.3% 200.93 US$2,757,894
2026-11-05 2026-11-05 PrS Proposed sale
2.1
NAMRATA SAROJ

Officer

Officer
13,092
312.31
US$527,258 		13,092 312.31 US$527,258
2026-10-13 2026-10-08 S Sale
3.1
Anderman Todd

Chief Legal Officer

Officer
98,841 -15.0%
281.20
US$1,436,092 		98,841 -15.0% 281.20 US$1,436,092
2026-10-08 2026-10-08 PrS Proposed sale
3.1
TODD ANDERMAN

Officer

Officer
11,984
7.29
US$87,315 		11,984 7.29 US$87,315
2026-10-06 2026-10-02 S Sale
2.7
Kaiser Peter

Chief Development Officer

Officer
9,990 -3.8%
7.05
US$70,430 		9,990 -3.8% 7.05 US$70,430
2026-10-06 2026-10-02 S Sale
3.7
Heier Jeffrey S.

Chief Scientific Officer

Officer
10,869 -3.4%
7.05
US$76,626 		10,869 -3.4% 7.05 US$76,626
2026-10-02 2026-10-02 PrS Proposed sale
2.7
PETER KAZUO KAISER

Officer

Officer
9,990
7.05
US$70,459 		9,990 7.05 US$70,459
2026-10-02 2026-10-02 PrS Proposed sale
3.7
JEFFREY S. HEIER

Officer

Officer
10,869
7.05
US$76,639 		10,869 7.05 US$76,639
2026-09-02 2026-08-31 PlS Planned sale
2.2
Notman Donald

Chief Operating Officer

Officer
1,099 -0.3%
10.24
US$11,254 		1,099 -0.3% 10.24 US$11,254
2026-08-31 2026-08-31 PrS Proposed sale
2.2
DONALD D NOTMAN JR.

Officer

Officer
1,099
10.24
US$11,252 		1,099 10.24 US$11,252
2026-08-26 2026-08-24 PlS Planned sale
2.7
Kaiser Peter

Chief Development Officer

Officer
3,035 -1.1%
10.77
US$32,687 		3,035 -1.1% 10.77 US$32,687
2026-08-26 2026-08-24 S Sale
2.9
Dugel Pravin

See Remarks

Executive Director
21,649 -0.8%
10.77
US$233,160 		21,649 -0.8% 10.77 US$233,160
2026-08-26 2026-08-24 S Sale
2.8
Nayak Sanjay

Chief Strategy Officer

Officer
1,897 -0.6%
10.78
US$20,450 		1,897 -0.6% 10.78 US$20,450
2026-08-26 2026-08-24 PlS Planned sale
3.7
Heier Jeffrey S.

Chief Scientific Officer

Officer
3,296 -1.0%
10.78
US$35,531 		3,296 -1.0% 10.78 US$35,531
2026-08-24 2026-08-24 PrS Proposed sale
2.8
SANJAY NAYAK

Officer

Officer
1,897
10.78
US$20,453 		1,897 10.78 US$20,453
2026-08-24 2026-08-24 PrS Proposed sale
2.9
PRAVIN DUGEL

Officer

Officer
21,649
10.77
US$233,186 		21,649 10.77 US$233,186
2026-08-24 2026-08-24 PrS Proposed sale
3.7
JEFFREY S. HEIER

Officer

Officer
3,296
10.78
US$35,532 		3,296 10.78 US$35,532
2026-08-24 2026-08-24 PrS Proposed sale
2.7
PETER KAZUO KAISER

Officer

Officer
3,035
10.77
US$32,702 		3,035 10.77 US$32,702
2026-06-05 2026-06-03 S Sale
1.9
Waheed Nadia

Chief Medical Officer

Officer
14,828 -4.7%
8.27
US$122,628 		14,828 -4.7% 8.27 US$122,628
2026-06-05 2026-06-03 S Sale
1.9
Waheed Nadia

Chief Medical Officer

Officer
14,828 -4.7%
8.27
US$122,628 		14,828 -4.7% 8.27 US$122,628
2026-06-03 2026-06-03 PrS Proposed sale
1.9
NADIA K. WAHEED

Officer

Officer
14,828
8.27
US$122,648 		14,828 8.27 US$122,648
2026-05-28 2026-05-26 S Sale
2.9
Dugel Pravin

See Remarks

Executive Director
21,156 -0.8%
8.20
US$173,479 		21,156 -0.8% 8.20 US$173,479
2026-05-28 2026-05-26 S Sale
3.7
Heier Jeffrey S.

Chief Scientific Officer

Officer
3,018 -0.9%
8.20
US$24,748 		3,018 -0.9% 8.20 US$24,748
2026-05-28 2026-05-26 S Sale
2.7
Kaiser Peter

Chief Development Officer

Officer
2,967 -1.1%
8.20
US$24,329 		2,967 -1.1% 8.20 US$24,329
2026-05-28 2026-05-26 S Sale
2.8
Nayak Sanjay

Chief Strategy Officer

Officer
1,858 -0.6%
8.20
US$15,236 		1,858 -0.6% 8.20 US$15,236
2026-05-26 2026-05-26 PrS Proposed sale
2.8
SANJAY NAYAK

Officer

Officer
1,858
8.20
US$15,237 		1,858 8.20 US$15,237
2026-05-26 2026-05-26 PrS Proposed sale
2.7
PETER KAZUO KAISER

Officer

Officer
2,967
8.20
US$24,334 		2,967 8.20 US$24,334
2026-05-26 2026-05-26 PrS Proposed sale
3.7
JEFFREY S. HEIER

Officer

Officer
3,018
8.20
US$24,745 		3,018 8.20 US$24,745
2026-05-26 2026-05-26 PrS Proposed sale
2.9
PRAVIN DUGEL

Officer

Officer
21,156
8.20
US$173,513 		21,156 8.20 US$173,513
2026-02-25 2026-02-23 S Sale
2.9
Dugel Pravin

See Remarks

Executive Director
20,056 -0.7%
8.28
US$166,064 		20,056 -0.7% 8.28 US$166,064
2026-02-25 2026-02-23 S Sale
2.7
Kaiser Peter

Chief Development Officer

Officer
2,810 -1.0%
8.28
US$23,267 		2,810 -1.0% 8.28 US$23,267
2026-02-25 2026-02-23 S Sale
3.7
Heier Jeffrey S.

Chief Scientific Officer

Officer
3,057 -0.9%
8.28
US$25,312 		3,057 -0.9% 8.28 US$25,312
2026-02-25 2026-02-23 S Sale
2.8
Nayak Sanjay

Chief Strategy Officer

Officer
1,759 -0.5%
8.28
US$14,565 		1,759 -0.5% 8.28 US$14,565
2026-02-23 2026-02-23 PrS Proposed sale
2.7
PETER KAZUO KAISER

Officer

Officer
2,810
8.28
US$23,268 		2,810 8.28 US$23,268
2026-02-23 2026-02-23 PrS Proposed sale
2.9
PRAVIN DUGEL

Officer

Officer
20,056
8.28
US$166,086 		20,056 8.28 US$166,086
2026-02-23 2026-02-23 PrS Proposed sale
3.7
JEFFREY S. HEIER

Officer

Officer
3,057
8.28
US$25,298 		3,057 8.28 US$25,298
2026-02-23 2026-02-23 PrS Proposed sale
2.8
SANJAY NAYAK

Officer

Officer
1,759
8.28
US$14,563 		1,759 8.28 US$14,563
2026-02-24 2026-02-20 S Sale
1.9
Waheed Nadia

Chief Medical Officer

Officer
3,510 -1.1%
7.74
US$27,167 		3,510 -1.1% 7.74 US$27,167
2026-02-24 2026-02-20 B Purchase
3.4
LINDSTROM RICHARD L MD
Non-Executive Director
60,229 +32.3%
7.66
US$461,354 		60,229 +32.3% 7.66 US$461,354
2026-02-20 2026-02-20 PrS Proposed sale
1.9
NADIA K. WAHEED

Officer

Officer
3,510
7.74
US$27,170 		3,510 7.74 US$27,170
2026-02-17 2026-02-12 S Sale
2.2
Notman Donald

Chief Operating Officer

Officer
11,446 -3.0%
9.04
US$103,472 		11,446 -3.0% 9.04 US$103,472
2026-02-17 2026-02-12 S Sale
2.8
Nayak Sanjay

Chief Strategy Officer

Officer
10,348 -3.0%
9.04
US$93,546 		10,348 -3.0% 9.04 US$93,546
2026-02-17 2026-02-12 S Sale
2.9
Dugel Pravin

See Remarks

Executive Director
124,882 -4.0%
9.04
US$1,128,933 		124,882 -4.0% 9.04 US$1,128,933
2026-02-17 2026-02-12 S Sale
1.9
Waheed Nadia

Chief Medical Officer

Officer
7,863 -2.4%
9.04
US$71,082 		7,863 -2.4% 9.04 US$71,082
2026-02-12 2026-02-12 PrS Proposed sale
2.2
DONALD D NOTMAN JR.

Officer

Officer
11,446
9.04
US$103,481 		11,446 9.04 US$103,481
2026-02-12 2026-02-12 PrS Proposed sale
2.9
PRAVIN DUGEL

Officer

Officer
124,882
9.04
US$1,128,584 		124,882 9.04 US$1,128,584
2026-02-12 2026-02-12 PrS Proposed sale
STEVE MEYERS

Officer

Officer
6,864
9.04
US$62,034 		6,864 9.04 US$62,034
2026-02-12 2026-02-12 PrS Proposed sale
2.8
SANJAY NAYAK

Officer

Officer
10,348
9.04
US$93,560 		10,348 9.04 US$93,560
2026-02-12 2026-02-12 PrS Proposed sale
1.9
NADIA K. WAHEED

Officer

Officer
7,863
9.04
US$71,082 		7,863 9.04 US$71,082
2026-02-04 2026-02-04 S Sale
2.2
Notman Donald

Chief Operating Officer

Officer
6,035 -1.6%
8.54
US$51,539 		6,035 -1.6% 8.54 US$51,539
2026-02-04 2026-02-04 S Sale
2.2
Notman Donald

Chief Operating Officer

Officer
6,035 -1.6%
8.54
US$51,539 		6,035 -1.6% 8.54 US$51,539
2026-02-04 2026-02-04 PrS Proposed sale
STEVE MEYERS

Officer

Officer
4,408
8.54
US$37,636 		4,408 8.54 US$37,636
2026-02-04 2026-02-04 PrS Proposed sale
2.2
DONALD D NOTMAN JR.

Officer

Officer
6,035
8.54
US$51,541 		6,035 8.54 US$51,541
2026-02-04 2026-02-02 S Sale
2.2
Notman Donald

Chief Operating Officer

Officer
5,455 -1.4%
9.14
US$49,859 		5,455 -1.4% 9.14 US$49,859
2026-02-02 2026-02-02 PrS Proposed sale
2.2
DONALD D NOTMAN JR.

Officer

Officer
5,455
9.14
US$49,873 		5,455 9.14 US$49,873
2026-02-02 2026-02-02 PrS Proposed sale
STEVE MEYERS

Officer

Officer
3,052
9.14
US$27,904 		3,052 9.14 US$27,904
2025-11-26 2025-11-24 S Sale
2.7
Kaiser Peter

Chief Development Officer

Officer
3,007 -1.5%
12.02
US$36,144 		3,007 -1.5% 12.02 US$36,144
2025-11-26 2025-11-24 S Sale
3.7
Heier Jeffrey S.

Chief Scientific Officer

Officer
3,469 -1.4%
12.04
US$41,767 		3,469 -1.4% 12.04 US$41,767
2025-11-26 2025-11-24 S Sale
2.8
Nayak Sanjay

Chief Strategy Officer

Officer
1,878 -0.7%
12.04
US$22,611 		1,878 -0.7% 12.04 US$22,611
2025-11-26 2025-11-24 S Sale
2.9
Dugel Pravin

See Remarks

Executive Director
19,530 -0.6%
12.04
US$235,141 		19,530 -0.6% 12.04 US$235,141
2025-11-24 2025-11-24 PrS Proposed sale
2.9
PRAVIN DUGEL

Officer

Officer
19,530
12.04
US$235,083 		19,530 12.04 US$235,083
2025-11-24 2025-11-24 PrS Proposed sale
2.8
SANJAY NAYAK

Officer

Officer
1,878
12.04
US$22,616 		1,878 12.04 US$22,616
2025-11-24 2025-11-24 PrS Proposed sale
2.7
PETER KAZUO KAISER

Officer

Officer
3,007
12.02
US$36,150 		3,007 12.02 US$36,150
2025-11-24 2025-11-24 PrS Proposed sale
3.7
JEFFREY S. HEIER

Officer

Officer
3,469
12.04
US$41,772 		3,469 12.04 US$41,772
2025-11-07 2025-11-05 S Sale
2.1
Saroj Namrata

Chief Business Officer

Officer
25,865 -12.9%
10.74
US$277,790 		25,865 -12.9% 10.74 US$277,790
2025-11-05 2025-11-05 PrS Proposed sale
2.1
NAMRATA SAROJ

Officer

Officer
25,865
10.74
US$277,909 		25,865 10.74 US$277,909
2025-10-10 2025-10-08 S Sale
3.1
Anderman Todd

Chief Legal Officer

Officer
11,132 -11.3%
12.34
US$137,369 		11,132 -11.3% 12.34 US$137,369
2025-10-08 2025-10-08 PrS Proposed sale
3.1
TODD ANDERMAN

Officer

Officer
11,132
12.34
US$137,400 		11,132 12.34 US$137,400
2025-10-06 2025-10-02 S Sale
3.7
Heier Jeffrey S.

Chief Scientific Officer

Officer
10,502 -4.0%
11.04
US$115,942 		10,502 -4.0% 11.04 US$115,942
2025-10-06 2025-10-02 S Sale
2.7
Kaiser Peter

Chief Development Officer

Officer
9,653 -4.7%
11.03
US$106,473 		9,653 -4.7% 11.03 US$106,473
2025-10-02 2025-10-02 PrS Proposed sale
3.7
JEFFREY S. HEIER

Officer

Officer
10,502
11.04
US$115,890 		10,502 11.04 US$115,890
2025-10-02 2025-10-02 PrS Proposed sale
2.7
PETER KAZUO KAISER

Officer

Officer
9,653
11.03
US$106,516 		9,653 11.03 US$106,516
2025-09-04 2025-09-02 PlS Planned sale
2.2
Notman Donald

See Remarks

Officer
1,066 -0.3%
12.43
US$13,250 		1,066 -0.3% 12.43 US$13,250
2025-09-02 2025-09-02 PrS Proposed sale
2.2
DONALD D NOTMAN JR.

Officer

Officer
1,066
12.43
US$13,245 		1,066 12.43 US$13,245
2025-08-27 2025-08-25 S Sale
3.7
Heier Jeffrey S.

Chief Scientific Officer

Officer
3,063 -1.2%
12.04
US$36,879 		3,063 -1.2% 12.04 US$36,879

See older Ocular Therapeutix, Inc. insider trades

Plus unlocks the full transaction history.

See localized pricing at checkout
Unlock Ocular Therapeutix, Inc. history with Plus

Billed monthly · Cancel anytime

Explore more

More insider trading research around Ocular Therapeutix, Inc.

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America